by Seini Moimoi | Jan 16, 2025
Aviceda Therapeutics is a biotechnology company developing next-generation immunomodulators with a proprietary High Affinity Ligands of Siglecs (HALOS™) nanotechnology platform to alleviate chronic, non-resolving inflammation. 
by Seini Moimoi | Dec 15, 2024
Veradermics is a clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions. 
by Seini Moimoi | Nov 15, 2024
Alentis Therapeutics is a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis. 
by Seini Moimoi | Feb 13, 2024
BioAge is a clinical-stage biotechnology company developing novel therapies for obesity and metabolic diseases discovered by harnessing the biology of aging. 
by Seini Moimoi | Dec 19, 2023
Lassen Therapeutics is a biotechnology company developing first-in-class monoclonal antibodies (mAb) targeting the IL-11 receptor (IL-11R), a central mediator of fibrosis and inflammation.